-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Krlef is an inactivated new crown vaccine developed by Beijing Kexing Zhongwei Biotechnology Co., Ltd. in cooperation with a number of cooperative units.
preclinical results of the vaccine have been published in the academic journal Science.
april 16 this year, the vaccine entered phase 1/2 clinical studies and showed good safety.
this year, Cochlear ZWEI and the Butantan Institute in Brazil reached a partnership to conduct a phase 3 clinical study in Kellefort, Brazil.
, 9,000 volunteers aged 18-59 have been vaccinated in Brazil with two doses of Kellefort, according to a press release issued by the Butantan Institute in Brazil.
35 percent of the volunteers showed mild adverse reactions after vaccination.
the most common adverse reactions after the first vaccination were pain at the injection site (19%) and headache (15%).
second vaccination, the most common adverse reactions were pain at the injection site (19%), headache (10%) and fatigue (4%).
0.1% of the volunteers had low fever and no serious adverse reactions were reported.
resources: s1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Retrieved October 20, 2020, from s Sinovac vaccine is safe, Brazil institute says. Retrieved October 20, 2020, from the Brazilian National Health Supervision Agency approved Beijing Kexing Zhongwei Biotechnology Co., Ltd. new crown inactivated vaccine Kelleford ™️ to carry out Phase III. Retrieved October 20, 2020, from.